# Efficacy and Safety of PERIOGEN in the Treatment of Periodontal Bone Defect

> **NCT00496847** · PHASE3 · COMPLETED · sponsor: **Virchow Group** · enrollment: 60 (actual)

## Conditions studied

- Intrabony Periodontal Defect

## Interventions

- **DRUG:** PERIOGEN
- **DRUG:** Beta TCP alone

## Key facts

- **NCT ID:** NCT00496847
- **Lead sponsor:** Virchow Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-08
- **Final completion:** 2009-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00496847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00496847, "Efficacy and Safety of PERIOGEN in the Treatment of Periodontal Bone Defect". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00496847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*